Microarray Borne little more than a decade ago, microarray-based assays have emerged as a critical tool for basic, translational, and correlative clinical cancer research. The types of assays performed with this technology that enables hundreds to millions of simultaneous measurements include gene expression profiling, global analysis of single nucleotide polymorphisms, ChlP-on-chip assays of gene promoter activity, and proteomic analyses. Microarray-based assays are valuable for discovery research, helping investigators identify and characterize signal transduction pathways involved in carcinogenesis, as well as, biomarkers for cancer detection, prognosis, and treatment decision-making. Although spotted arrays are still used, especially for custom arrays and technology development, numerous array manufacturers have entered the marketplace making the technology much more cost-effective and reproducible. The mission of the Microarray Shared Resource is to provide Cancer Center investigators with high quality standard, cutting-edge, and custom microarray assays, as well as, consultation on experimental design and training/education about microarray methods. The Cancer Center Microarray Shared Resource has been in operation since September, 1999, when it began as a developmental shared resource with institutional support. Partial funding from the DC San Diego CCSG-started in April, 2001. Over the years the Microarray Shared Resource has grown to include three separate laboratories: (1) the VA GeneChip Core facility, located in VA-leased space in the UC San Diego Stein Building;(2) the Biomedical Genomics Microarray (BIOGEM) Core facility, located in the Leichtag Building on the UC San Diego La Jolla campus;and (3) the Biomarker Core laboratory, located in the Moores Cancer Center Building. The facilities and services provided these Core laboratories have been selected to be non-overlapping in order to mitigate the costs of microarray instrumentation, which frequently need upgrading for this rapidly evolving field. The confederation of these facilities is supported, in terms of organization and funding, by the administration of the Moores Cancer Center, the UCSD School of Medicine, and the San Diego Veterans Medical Research Foundation. The Microarray Resource Oversite Committee directs the operational policies and technology issues for the Facility. To date, the Facility has served the laboratories of more than 50 different Cancer Center investigators. It is anticipated that this use will continue to expand as costs for microarray assays decrease and new, planned microarray services in the Facility come online.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Akers, Johnny C; Ramakrishnan, Valya; Yang, Isaac et al. (2016) Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer Biomark 17:125-32
Hoffmann, Hanne M; Trang, Crystal; Gong, Ping et al. (2016) Deletion of Vax1 from Gonadotropin-Releasing Hormone (GnRH) Neurons Abolishes GnRH Expression and Leads to Hypogonadism and Infertility. J Neurosci 36:3506-18
Baumgartner, Joel M; Kwong, Thomas G; Ma, Grace L et al. (2016) A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 23:1609-17
Meyskens Jr, Frank L; Mukhtar, Hasan; Rock, Cheryl L et al. (2016) Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst 108:
Hussain, Timon; Savariar, Elamprakash N; Diaz-Perez, Julio A et al. (2016) Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers. Head Neck 38:715-23
Singh, Alok R; Joshi, Shweta; Zulcic, Muamera et al. (2016) PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma. PLoS One 11:e0150836
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Nuyen, Brian A; Fox, Rina S; Malcarne, Vanessa L et al. (2016) Excessive Daytime Sleepiness as an Indicator of Depression in Hispanic Americans. Hisp Health Care Int 14:116-23
Ghosh, Pradipta; Aznar, Nicolas; Swanson, Lee et al. (2016) Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin. Curr Protoc Chem Biol 8:265-298
Johns, Claire; Seav, Susan M; Dominick, Sally A et al. (2016) Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat 156:415-26

Showing the most recent 10 out of 699 publications